爱舍伦IPO：实控人张勇亲属控制多家企业，是否存在同业竞争遭问询

Core Viewpoint - Aishalon Medical Technology Group Co., Ltd. is undergoing an IPO process, with inquiries regarding potential competition from companies controlled by relatives of the actual controller, Zhang Yong [3][4]. Financial Performance - Aishalon's revenue for the years 2021 to 2023 was 573 million, 574 million, and 575 million respectively, while net profits were approximately 99.88 million, 62.80 million, and 66.94 million [3]. Ownership Structure - Zhang Yong directly holds 1.97% of the company and indirectly controls 88.69% through various entities, including a controlling stake via Aishalon Management Consulting [3][4]. Related Companies - Relatives of the actual controller, including major shareholder Ren Tao, control several companies such as Zhangjiagang Baide Metal Products Co., Ltd. and Suzhou Zhiyi Medical Devices Co., Ltd. [4][5]. Competition Analysis - Aishalon asserts that there is no significant competition with the companies controlled by Ren Tao, as their main business activities do not overlap with Aishalon's core operations [5][6]. Business Focus - The company does not engage in mask production and has no plans to do so in the future, indicating that there is no competitive overlap with the mask-related businesses of Zhangjiagang Zhiyi and Suzhou Zhiyi [6][7]. Historical Context - In 2020, to address competition and regulate related transactions, Aishalon acquired non-mask business assets from companies controlled by Ren Tao, reflecting a strategic decision to avoid conflicts in business focus [7].